Merck IIT: RRP Pembro and Lenvatinib
Merck IIT: RRP Pembro and Lenvatinib
Recruiting · NCT04645602 · Registry updated 2026-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Merck IIT: RRP Pembro and Lenvatinib | lung disorder, recurrent respiratory papillomatosis, respiratory system disorder | Recruiting | Phase 2 | 2026-07-02 | NCT04645602 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eisai Inc. | 40 |
| Merck Sharp & Dohme LLC | 650 |
| Yale University | 458 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yale University | New Haven | United States | 76 |